Clinical evaluation of the neuroprotective effect of α-tocopherol against glaucomatous damage

European Journal of Ophthalmology

Volumn 17, Issue 4, 2007, Pages 528-533

  Engin, Kaya N ^a,c   Engin, G ^a,b   Kucuksahin, H ^a   Oncu, M ^a   Guvener, B ^b  

^a V Gureba Education Hospital   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Doppler; Glaucoma; Neuroprotection; Tocopherol; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL;

ADULT; ARTICLE; CILIARY ARTERY; CLINICAL ARTICLE; CLINICAL EVALUATION; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DISEASE COURSE; GLAUCOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NEUROPROTECTION; OPHTHALMIC ARTERY; PRIORITY JOURNAL; PULSATILE FLOW; STATISTICAL SIGNIFICANCE; VISUAL FIELD;

EID: 35348987581     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210701700408     Document Type: Article

References (23)

1. Packer L. Protective role of vitamin E in biological systems. Am J Clin Nutr 1991; 53 (Suppl): S1050-5.
2. Traber MG, Packer L. Vitamin E beyond antioxidant function. Am J Clin Nutr 1995; 62: 1501s-9s.
3. Özer NK, irikçi Ö, Taha S, et al. Prevention of atherosclerosis by α-tocopherol in smooth muscle cells by a mechanism involving signal transduction modulation. In: Özben T, ed. Free Radicals, Oxidative Stress and Antioxidants. New York: Plenum Press, 1998; 333-42.
4. Haas AL, Boscoboinik D, Mojon DS, et al. Vitamin E inhibits proliferation of human Tenon's capsule fibroblasts in vitro. Ophthalmic Res 1996; 28: 171-5.
5. Wiederholt M, Thieme H, Stumpft F. The regulation of trabecular meshwork and ciliary muscle contractility. Prog Retin Eye Res 2000; 19: 271-95.
6. Alexander JP, Acott TS. Involvement of protein kinase C in TNFalpha regulation of trabecular matrix metalloproteinases and TIMPs. Invest Ophthalmol Vis Sci 2001; 42: 2831-8.
7. Bull ND, Barnett NL. Antagonists of protein kinase C inhibit rat retinal glutamate transport activity in situ. J Neurochem 2002; 81: 472-80.
8. Kunisaki M, Bursell S, Clermont AC, et al. Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway. Am J Physiol 1995; 269: 239-46.
9. Lee IK, Koya D, Ishi H, et al. d-α-tocopherol prevents the hyperglycemia induced activation of diacylglycerol (DAG)-protein kinase C (PKC) pathway in vascular smooth muscle cell by an increase of DAG kinase activity. Diabetes Res Clin Pract 1999; 45: 183-90.
10. Alvarez RA, Liou GI, Fong SL, et al. Levels of α- and γ-tocopherol in human eyes: evaluation of the possible role of IRBP in intraocular α-tocopherol transport. Am J Clin Nutr 1987; 46: 481-7.
11. Nagata M, Kawazu K, Midori Y, et al. Intracameral and lenticular penetration of locally applied stable isotope-labeled vitamin E. Jpn J Ophthalmol 2001; 45: 125-7.
12. Harris A. Ocular bloodflow and glaucoma. In: Choplin NT, Lundy CL, ed. Atlas of Glaucoma. Malden: Blackwell Science Inc.; 1998: 169-80.
13. Tranquart F, Berges O, Koskas P, et al. Color Doppler imaging of orbital vessels: personal experience and literature review. J Clin Ultrasound 2003; 31: 258-73.
14. Smith JJ, Kampine JP. Circulatory Physiology; The Essential. Vol. 3. Baltimore: Williams & Wilkins, 1990.
15. Rankin SJ, Walman BE, Buckley AR, et al. Color Doppler imaging and spectral analysis of the optic nerve vasculature in glaucoma. Am J Ophthalmol 1994; 119: 685-92.
16. Inan U, Ermis S, Yucel A, Ozturk F. The effects of latanoprost and brimonidine on blood flow velocity of the retrobulbar vessels: a 3-month clinical trial. Acta Ophthalmol Scand 2003; 81: 155-60.
17. Rainer G, Dorner GT, Garhofer G, Vass C, Pfleger T, Schmetterer L. Changing antiglaucoma therapy from timolol to betaxolol: effect on ocular blood flow. Ophthalmologica 2003; 217: 288-93.
18. Rojanopongpun P, Drance SM, Morrison BJ. Ophthalmic artery flow velocity in glaucomatous and normal subject. Br J Ophthalmol 1993; 77: 25-9.
19. Hayrey SS. Vascular factors in the pathogenesis of glaucomatous optic neuropathy. In: Drance SM, ed. International Symposium on Glaucoma, Ocular Blood Flow and Drug Treatment, 1st ed. Baltimore: Williams & Wilkins, 1992; 33-41.
20. Choplin NT. Psychophysical and electrophysiological testing in glaucoma: visual fields and other functional tests. In: Choplin NT, Lundy CL, ed. Atlas of Glaucoma. 1st ed. Malden: Blackwell Science Inc. 1998; 75-103.
21. Cellini M, Caramazza N, Mangiafico P, et al. Fatty acid use in glaucomatous optic neuropathy treatment. Acta Ophthalmol Scand 1998; 227: 41-2.
22. Stark H. Studies with the computer-guided perimeter "Peritest" on the effect of Cosaldon A+E on glaucomatous visual field defects. Ophthalmologica 1985; 191: 238-49.
23. Sies H, Murphy ME. Role of tocopherols in the protection of biological systems against oxidative damage. J Photochem Photobiol 1991; 8: 211-8.